Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Titus B. Ball currently holds 15,340 shares of BeiGene, Ltd. (BGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Titus B. Ball has been a net seller of BGNE stock. They have purchased $0 and sold $112.9K worth of shares.
Titus B. Ball's most recent insider trade was on Sep 1, 2026, when they sold 132 shares at $355.86 per share.
Titus B. Ball serves as Executive at BeiGene, Ltd. (BGNE). They have executed 19 insider transactions totaling $112.9K over their tenure at the company.
Titus B. Ball holds the position of Executive at BeiGene, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Titus B. Ball has shown a selling trading pattern, with $0 in total purchases and $112.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Titus B. Ball was on Jan 1, 2021, when they sold $76.1K worth of CSL shares. This transaction involved 487 shares at $156.18 per share.
Titus B. Ball currently owns 15,340 shares of BeiGene, Ltd. (BGNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Titus B. Ball's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Titus B. Ball has 19 Form 4 filings on record as an insider at BeiGene, Ltd..
Set alerts for Titus B. Ball and 40,000+ other insiders.